EUVIMEDEUVIMED entdecken
Crossref

Apoptosis antagonizing transcription factor‐mediated liver damage and inflammation to cancer: Therapeutic intervention by curcumin in experimental metabolic dysfunction associated steatohepatitis‐hepatocellular carcinoma

Akshatha N Srinivas, Diwakar Suresh, Saravana B Chidambaram, Prasanna K Santhekadur, Divya P Kumar iD

Journal of Cellular Physiology · 2024

DOI: 10.1002/jcp.31151 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Physiology, 2024. Verfasst von Akshatha N Srinivas und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, CEMR lab, JSS Medical College, JSS Academy of Higher Education and Research, Mysuru, Karnataka, India. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Curcumin, Fatty Liver, Liver Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Ramalingaswami Re-entry Fellowship from the Department of Biotechnology, Extramural Ad-hoc Grant from the Indian Council of Medical Research (ICMR), Senior Research Fellowship (SRF) from ICMR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In tandem with the expanding obesity pandemic, the prevalence of metabolic dysfunction associated steatohepatitis (MASH, formerly known as NASH)‐ driven hepatocellular carcinoma (HCC) is predicted to rise globally, creating a significant need for therapeutic interventions. We previously identified the upregulation of apoptosis antagonizing transcription factor (AATF), which is implicated in facilitating the progression from MASH to HCC. The objective of this study was to examine whether the intervention of curcumin could alleviate AATF‐mediated MASH, inhibit tumor growth, and elucidate the underlying mechanism. A preclinical murine model mimicking human MASH‐HCC was employed, subjecting mice to either a chow diet normal water (CDNW) or western diet sugar water (WDSW) along with very low dose of carbon tetrachloride (CCl 4 ‐ 0.2 μL/g, weekly). Mice receiving curcumin (CUR) alongside WDSW/CCl 4 exhibited significant improvements, including reduced liver enzymes, dyslipidemia, steatosis, inflammation, and hepatocellular ballooning. Curcumin treatment also suppressed hepatic expression of inflammatory, fibrogenic, and oncogenic markers. Of note, there was a significant reduction in the expression of AATF upon curcumin treatment in WDSW/CCl 4 mice and human HCC cells. In contrast, curcumin upregulated Kruppel‐like factor 4 (KLF4) in MASH liver and HCC cells, which is known to downregulate sp1 (specificity protein‐1) expression. Thus, curcumin treatment effectively inhibited the progression of MASH to HCC by downregulating the expression of AATF via the KLF4‐Sp1 signaling pathway. These preclinical findings establish a novel molecular connection between curcumin and AATF in reducing hepatocarcinogenesis, and provide a strong rationale for the development of curcumin as a viable treatment for MASH‐HCC in humans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularCurcuminFatty LiverLiver NeoplasmsNon-alcoholic Fatty Liver DiseaseAnimalsHumansMiceApoptosisApoptosis Regulatory ProteinsInflammationRepressor ProteinsTranscription FactorsNuclear Proteins

Stichwörter der Autor:innen

apoptosis antagonizing transcription factorcurcuminhepatocellular carcinomainflammationmetabolic dysfunction associated steatohepatitistumorigenesis

Substanzen

Apoptosis Regulatory ProteinsCurcuminRepressor ProteinsTranscription FactorsAatf protein, mouseNuclear Proteins

Autor:innen und Institutionen

  • Department of Biochemistry, CEMR lab, JSS Medical College, JSS Academy of Higher Education and Research, Mysuru, Karnataka, India.
  • Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru, Karnataka, India.

ORCID-Profile: Divya P Kumar

Förderung

  • Ramalingaswami Re-entry Fellowship from the Department of Biotechnology
  • Extramural Ad-hoc Grant from the Indian Council of Medical Research (ICMR)
  • Senior Research Fellowship (SRF) from ICMR
  • Department of Science and Technology's Promotion of University Research and Scientific Excellence

Zitieren

APA

Srinivas, A. N., Suresh, D., Chidambaram, S. B., Santhekadur, P. K., & Kumar, D. P. (2024). Apoptosis antagonizing transcription factor‐mediated liver damage and inflammation to cancer: Therapeutic intervention by curcumin in experimental metabolic dysfunction associated steatohepatitis‐hepatocellular carcinoma. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.31151

Vancouver

Srinivas AN, Suresh D, Chidambaram SB, Santhekadur PK, Kumar DP. Apoptosis antagonizing transcription factor‐mediated liver damage and inflammation to cancer: Therapeutic intervention by curcumin in experimental metabolic dysfunction associated steatohepatitis‐hepatocellular carcinoma. Journal of Cellular Physiology. 2024. doi:10.1002/jcp.31151

BibTeX
@article{Srinivas2024,
  author = {Srinivas, Akshatha N and Suresh, Diwakar and Chidambaram, Saravana B and Santhekadur, Prasanna K and Kumar, Divya P},
  title = {Apoptosis antagonizing transcription factor‐mediated liver damage and inflammation to cancer: Therapeutic intervention by curcumin in experimental metabolic dysfunction associated steatohepatitis‐hepatocellular carcinoma},
  journal = {Journal of Cellular Physiology},
  year = {2024},
  doi = {10.1002/jcp.31151}
}
Kostenlos starten →